pyy and glp 1 ghrelin Figure from Ghrelin, CCK, GLP-1, PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB GLP-1 receptor assay: drug discovery – The role of oxyntomodulin and

Safety Profile and Potential Side Effects BPC-157 demonstrates an excellent safety profile in clinical studies, with most side effects being mild and transient

Again, the dose gap is orders of magnitude

Genetically Engineered Plant Delivery Systems Plants have been researched as green bioreactors for producing recombinant proteins

However, GLP-1 can activate GCGR in cells, and GCGR is able to reduce the number of docking granules by coupling and activating inhibitory GTP binding protein (Gi/o), thus inhibiting the secretion of glucagon, which is independent of GLP-1R (Gandasi et al., 2024)

A capsule described as "500 mcg" may have a total fill of hundreds of milligrams of powder with only 500 mcg (0.5 mg) of BPC-157